Long-Term Surgical Outcomes and Recurrence Risk Stratification in Rathke's Cleft Cysts: Proposal of a Novel Scoring System.
Recurrence of Rathke's cleft cysts occurs in 11.1% of patients after surgery, with preoperative arginine vasopressin deficiency being a significant predictor.
Where it sits
this study against the rest of the lypressin corpusSummary and findings
This study assessed long-term surgical outcomes and recurrence predictors in patients with Rathke's cleft cysts (RCCs) who underwent surgery. A novel seven-point recurrence risk score was proposed based on clinical, radiological, and pathological variables. Recurrence occurred in 11.1% of patients after a median follow-up of 118.5 months.
Abstract
<h4>Background</h4>Rathke's cleft cysts (RCCs) are benign, nonneoplastic sellar lesions arising from Rathke's pouch remnants. Although surgery provides effective symptom relief, recurrence remains a major concern, and no validated tool exists to guide postoperative surveillance.<h4>Objective</h4>To assess long-term surgical outcomes, identify recurrence predictors, and propose a novel recurrence risk score for RCCs.<h4>Methods</h4>Patients with histopathologically confirmed RCCs who underwent surgery between January 2000 and December 2023 at a tertiary neurosurgical center were retrospectively analyzed. Clinical, radiological, and pathological variables were evaluated for recurrence prediction. A multivariate logistic regression model generated a seven-point risk score, validated through receiver operating characteristic analysis and Kaplan-Meier survival curves.<h4>Results</h4>Thirty-six patients (median age: 39.5 years; 55.6% female) were included, with a median follow-up of 100.5 months. Headache (72%) was the most frequent symptom, followed by visual and endocrine disturbances. Gross total resection was achieved in 75%. Recurrence occurred in four patients (11.1%) after a median of 118.5 months. Preoperative arginine vasopressin deficiency (AVP-D) independently predicted recurrence (OR: 8.84, <i>p</i> = 0.040), while subtotal excision, inflammation, and squamous metaplasia showed borderline significance. The composite seven-point score demonstrated excellent discrimination (AUC: 0.957, <i>p</i> = 0.003), with scores > 5 correlating with higher recurrence risk (log-rank <i>p</i> = 0.011).<h4>Conclusion</h4>RCC recurrence is influenced by preoperative AVP-D, surgical extent, and cyst wall histopathology. The proposed risk score enables reliable recurrence stratification and may inform individualized postoperative surveillance strategies.
Background
Rathke's cleft cysts (RCCs) are benign lesions that can cause significant symptoms and require surgical intervention. Although surgery is effective for symptom relief, recurrence remains a concern, and there is a lack of validated tools for postoperative monitoring. This study aims to address these issues by evaluating long-term outcomes and establishing a scoring system for recurrence risk.
Methods
This retrospective analysis included patients with histopathologically confirmed RCCs who underwent surgery from January 2000 to December 2023 at a tertiary neurosurgical center. A total of 36 patients were included, with clinical, radiological, and pathological variables assessed for recurrence prediction. A multivariate logistic regression model was used to create a seven-point risk score, validated through receiver operating characteristic analysis and Kaplan-Meier survival curves.
Results
The primary endpoint indicated that recurrence occurred in four patients (11.1%) after a median of 118.5 months. The study found that preoperative arginine vasopressin deficiency (AVP-D) was a significant predictor of recurrence with an odds ratio of 8.84 (p = 0.040). The seven-point risk score showed excellent discrimination with an area under the curve of 0.957 (p = 0.003).
Interpretation
The findings suggest that preoperative AVP-D is a strong predictor of recurrence, which aligns with previous literature indicating the importance of hormonal factors in RCC outcomes. However, the clinical significance of the seven-point risk score needs further validation in larger cohorts. Limitations such as the small sample size and retrospective design may affect the robustness of these conclusions and their applicability in clinical practice.
Key findings
- Recurrence occurred in four patients (11.1%) after a median of 118.5 months.
- Gross total resection was achieved in 75%.
- Preoperative arginine vasopressin deficiency (AVP-D) independently predicted recurrence (OR: 8.84, p = 0.040).
- The composite seven-point score demonstrated excellent discrimination (AUC: 0.957, p = 0.003).
- Scores > 5 correlated with higher recurrence risk (log-rank p = 0.011).
Limitations
- small sample size of 36 patients
- retrospective design may introduce bias
- single-center study limits generalizability
- no external validation of the scoring system